METH-2 Activators
METH-2 Activators encompass a diverse array of chemical compounds that facilitate the functional activity of METH-2 through intricate and specific signaling pathways. Forskolin and PMA enhance METH-2 activity by increasing levels of cAMP and activating PKC, respectively, both of which can lead to the phosphorylation of METH-2 or its regulatory partners, directly augmenting METH-2's functional capacity. Epigallocatechin gallate and Genistein contribute to METH-2 activation by inhibiting various kinases, which may reduce negative regulation on METH-2, thus indirectly promoting its activity. Sphingosine-1-phosphate, by engaging with its receptors, might activate downstream effectors that modulate METH-2 activity, possibly through alterations in membrane association or activity state. Similarly, the PI3K inhibitors LY294002 and Wortmannin might enhance METH-2 function by disrupting competitive signaling pathways, leading to favorable post-translational modifications of METH-2 or shifts in its subcellular localization.
Further modulation of METH-2's activity is achieved through the manipulation of intracellular calcium levels by compounds such as Thapsigargin and A23187, which can activate calcium-sensitive pathways that upregulate METH-2 activity. The p38 MAPK inhibitor SB203580 and the MEK1/2 inhibitor U0126 could also skew signaling towards METH-2 activation by altering the phosphorylation landscape, either directly on METH-2 or on proteins within its activation pathway.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP, which activates PKA. PKA could phosphorylate METH-2 or associated regulatory proteins, leading to increased METH-2 functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin inhibits multiple kinases, potentially reducing negative regulation on METH-2 or its pathway components, thereby enhancing METH-2 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which through downstream effectors, might increase METH-2 activity by altering its membrane association or activity state. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could reduce competitive signaling, shifting equilibrium towards pathways that enhance METH-2 activity through post-translational modifications or localization changes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An SERCA pump inhibitor that raises intracellular calcium levels, potentially activating calcium-sensitive pathways that lead to METH-2 activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A PKC activator that could modulate intracellular signaling pathways, leading to phosphorylation events enhancing METH-2 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that might shift signaling towards pathways that positively regulate METH-2 activity by altering the phosphorylation state of METH-2 or associated proteins. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium, potentially enhancing METH-2 activity by activating calcium-dependent signaling mechanisms. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that could reduce competing signals, enhancing pathways that lead to METH-2 activation through changes in protein interactions or phosphorylation states. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that could indirectly enhance METH-2 activity by altering downstream signaling pathways, leading to a change in METH-2's activation state. | ||||||